APA (7th ed.) Citation

M, R., KM, S., PH, F., M, F., TW, S., D, L., . . . TH, D. (2022). Multicenter dose-escalation Phase I trial of mitomycin C pressurized intraperitoneal aerosolized chemotherapy in combination with systemic chemotherapy for appendiceal and colorectal peritoneal metastases: Rationale and design. Pleura and peritoneum, 7(4), 169. https://doi.org/10.1515/pp-2022-0116

Chicago Style (17th ed.) Citation

M, Raoof, et al. "Multicenter Dose-escalation Phase I Trial of Mitomycin C Pressurized Intraperitoneal Aerosolized Chemotherapy in Combination with Systemic Chemotherapy for Appendiceal and Colorectal Peritoneal Metastases: Rationale and Design." Pleura and Peritoneum 7, no. 4 (2022): 169. https://doi.org/10.1515/pp-2022-0116.

MLA (9th ed.) Citation

M, Raoof, et al. "Multicenter Dose-escalation Phase I Trial of Mitomycin C Pressurized Intraperitoneal Aerosolized Chemotherapy in Combination with Systemic Chemotherapy for Appendiceal and Colorectal Peritoneal Metastases: Rationale and Design." Pleura and Peritoneum, vol. 7, no. 4, 2022, p. 169, https://doi.org/10.1515/pp-2022-0116.